Senior insider sale
Sr. V.P., Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$928.6K
33.65K shares
What this filing means
MARTIN TAMI TILLOTSON plans to sell 33.65K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $928.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2024ACC: 0001950047-24-005426
Officer· Sr. V.P., Regulatory Affairs
Since Feb 2020
33.65K
Shares to sell
$928.6K
Approx. market value
6.25K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
7/15/2024
6.25KTotal acquired6.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2024 | Exercise of options under a registered plan Cash | 6.25K | — |
| Total | 6.25K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
13.90K
Market value
$389.2K
7/11/2024
—Completed
Units to sell
3.50K
Market value
$92.7K
7/9/2024
—Completed
Units to sell
5K
Market value
$130.9K
7/8/2024
—Completed
Units to sell
5K
Market value
$134.2K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.25K
Market value
$181.5K
7/15/2024
Total
Units
33.65K
Value
$928.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/11/2024 | 13.90K | $389.2K | — | Completed |
7/9/2024 | 3.50K | $92.7K | — | Completed |
7/8/2024 | 5K | $130.9K | — | Completed |
6/25/2024 | 5K | $134.2K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2024 | 6.25K | $181.5K | NASDAQ | Planned |
| Total | 33.65K | $928.6K | ||